Svetlana E. Glova

Svetlana E. Glova

Auto-generated profile, based on publicly available information

Svetlana E. Glova

Rostov State Medical University

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2019 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
LKL. A. Khaisheva
L. A. Khaisheva
SGS. E. Glova
S. E. Glova
VSV. A. Suroedov
V. A. Suroedov
ASA. S. Samakaev
A. S. Samakaev
SSS. V. Shlyk
S. V. Shlyk
Aim. To study the prescribed drug therapy, as well as adherence to it in patients with acute coronary syndrome (ACS) in real clinical practice within a year after the index event. Material and methods. The study included 327 patients who were in hospital treatment with ACS: 199 patients (60.9%) with unstable angina (UA) and 128 (39.1%) – with acute myocardial infarction (AMI). The prescribed treatment and adherence to therapy were evaluated within 12 months after the coronary event. Therapy prescribed to patients was compared with current clinical guidelines for the treatment of patients with ACS. Results. 67% of patients completed the clinical study Adherence to prescribed medication within 12 months after ACS was maximal for ACE inhibitors/angiotensin receptor blockers (83.6%), dual antiplatelet therapy (79.9%) and β-blockers (78.1%), and minimal for lipid-lowering drugs (statins; 61.6%). A significant decrease in adherence was revealed in 6 and 12 months from the initiation of therapy. Significantly higher level of adherence to DAT was found in patients with AMI compared with patients with UA (p<0.05). When analyzing the frequency of occurrence of endpoints, it was found that patients who did not adhere to treatment significantly more often had hospitalizations due to UA (15.1% vs 7.4%; p<0.05), AMI (16.9% vs 8.1%; p<0.05), death from cardiovascular causes (13% vs 10.4%; p<0.05). Conclusion. Therapy prescribed at the outpatient stage in patients with ACS in the Rostov Region corresponds to the modern clinical recommendations. Six months after hospital discharge adherence to drug therapy in patients is reduced, which requires more careful outpatient monitoring during this period. In patients who are not adherent to treatment, cardiovascular complications are significantly more frequent.

27 November 2021 in South Russian Journal of Therapeutic Practice
Verified
Journal Article
Open access
PDF file
SGS. E. Glova
S. E. Glova
ИРИ. В. Разумовский
И. В. Разумовский
Chronic obstructive pulmonary disease (COPD) has a close relationship with the development of heart failure and atrial fibrillation (AF). In the pathogenesis of AF in patients with COPD, decreased oxygenation, hypercapnia, pulmonary hypertension, diastolic dysfunction, oxidative stress, inflammation, changes in atrial size, and the use of respiratory drugs for the treatment of COPD are important. Understanding the relationship between COPD and AF is of particular importance because the presence of arrhythmias has a significant impact on mortality, especially in exacerbations of COPD. In the presence of COPD, patients with AF have a more rapid progression of AF, recurrence of AF after catheter ablation, and an increase in mortality from cardiovascular diseases. Treatment of the underlying disease, correction of hypoxia and acid‑base imbalance is the first line therapy for patients with COPD who develop AF. Cardioselective β‑blockers are safe and can be used for COPD. AF ablation is effective and safe and improves the quality of life of these patients.

16 March 2022 in South Russian Journal of Therapeutic Practice
Verified
Journal Article
Open access
PDF file
SGS. E. Glova
S. E. Glova
LKL. A. Khaisheva
L. A. Khaisheva
ИРИ. В. Разумовский
И. В. Разумовский
SSS. V. Shlyk
S. V. Shlyk
Objective: to study the dynamics of microcirculation indices in patients with arterial hypertension, chronic obstructive pulmonary disease, and in their combination. Material and methods: the study included 226 people, of which 66 people were patients with chronic obstructive pulmonary disease, 54 patients with arterial hypertension, 74 people with a combination of chronic obstructive pulmonary disease and arterial hypertension, 32 relatively healthy volunteers. To assess the circulatory bed, we used a computerized ultrasonic Doppler instrument Minimax-Doppler-K, LLC JV «Minimax». Results: in patients with COPD and AH, microcirculation maladjustment is observed, manifested by a paradoxical reaction to stimuli in the form of an indirect occlusive effect. When studying the correlations between the indicators of the microvasculature and clinical and instrumental data, it was found that there is a relationship between the linear velocities of the microvasculature and the age, the smoking index, systolic blood pressure, pulse blood pressure. A correlation relationship was established between the FEV1 and the maximum linear systolic velocity along the maximum velocity curve in patients with COPD and COPD and AH. Conclusion: COPD and hypertension are comorbid conditions that lead to more pronounced microcirculatory changes, which can have a mutual effect on the course of these diseases.

21 June 2023 in South Russian Journal of Therapeutic Practice
Verified
Journal Article
Open access
PDF file
ASA. S. Samakaev
A. S. Samakaev
SGS. E. Glova
S. E. Glova
EZE. E. Zimoveyskaya
E. E. Zimoveyskaya
LKL. A. Khaisheva
L. A. Khaisheva
SSS. V. Shlyk
S. V. Shlyk
Objective: to study the level of type 1 vascular endothelial adhesion molecule in patients with coronary heart disease depending on the stage of chronic kidney disease. Material and methods: the study included 115 patients, mean age was 67.56±12.42 years (63 men, 52 women) with ischemic heart disease (CAD), stable angina (tension), functional class 1–3, chronic kidney disease (CKD) C1–C3. The level of the vascular endothelial adhesion molecule type 1 (VCAM 1) was assessed using the enzyme immunoassay kit for the quantitative determination of human VCAM 1 ThermoFisher scientific. Results: in patients with CAD and CKD, the level of serum VCAM 1 progressively increases as angina pectoris worsens and can be regarded as an early marker of CAD progression. The level of VCAM 1 does not depend on the stage of CKD. When studying the correlation relationships between the level of serum VCAM 1 and clinical and laboratory data, it was found that there is a correlation relationship between VCAM 1 and the level of SBP and DBP. Conclusion: in patients with CAD and CKD, it is advisable to use the determination of the level of VCAM 1 to identify patients with a high risk of cardiovascular complications.

1 January 2006
Verified
Journal Article
Closed access
LKL I Katel'Nitskaia
L I Katel'Nitskaia
DID N Ivanchenko
D N Ivanchenko
LKL A Khansheva
L A Khansheva
LKL V Kholoshina
L V Kholoshina
SGS E Glova
S E Glova
SPS A Pleskachev
S A Pleskachev

30 May 2022 in "Arterial’naya Gipertenziya" ("Arterial Hypertension")
Verified
Journal Article
Open access
PDF file
LKL. A. Khaisheva
L. A. Khaisheva
SGS. E. Glova
S. E. Glova
SSS. V. Shlyk
S. V. Shlyk
Objective. Evaluation of the effectiveness and safety of antihypertensive therapy with a fixed dose combination of amlodipine/indapamide in patients with hypertension (HTN) and chronic obstructive pulmonary disease (COPD).Design and methods. We conducted a non-randomized, open, single-center study, which included 74 comorbid patients (62 men, 12 women) with stage I–II HTN, grade 1–2 HTN, moderate cardiovascular risk and COPD (GOLD I–III). We also assessed respiratory function, the parameters of the microcirculatory bed, vascular stiffness, level of tumor necrosis factor α (TNF-α). For HTN, after the examination all patients were prescribed a fixed combination of amlodipine and indapamide (Arifam, Les Laboratoires Servier, France). The observation period was 6 months.Results. The study was completed by 58 patients who achieved blood pressure (BP values of 132,7 + 4,8 mm Hg), 54% patients took the initial dose of amlodipine/indapamide was 5/1,5 mg and in 46% patients, the dose of the drug was increased to 10/1,5 mg. After 6 months of treatment, a statistically significant increase in forced expiratory volume in 1st second (FEV1) was detected (p < 0,05), decrease in the average linear velocity along the maximum velocity curve (p < 0,05), Purcelo peripheral resistance index (p < 0,05), pulse wave propagation velocity in the elastic arteries, which was increased at the beginning of the study (p < 0,05), TNF-α (p < 0,05).Conclusions. The administration of a fixed combination of amlodipine/indapamide in patients with COPD and HTN leads to the achievement of target BP levels, reduction of vascular stiffness, reduction in TNF-α level, improvement of microcirculatory blood flow. The combination is safe and well-tolerated.